| Financial Year |
September 30 2020 |
| Monetary Funds |
2,029,247.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,146,161.65 |
| Advances to Suppliers |
162,473.85 |
| Other Receivables |
2,113,065.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,537,544.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
6,988,492.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
899,102,348.86 |
| Investment Properties |
39,671,688.28 |
| Fixed Assetes |
1,479,626.68 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
56,578.25 |
| Deferred Income Tax Assets |
15,684,710.84 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
957,214,952.91 |
| Total Assets |
964,203,445.59 |
| Short-Term Loans |
106,189,126.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
12,846,107.43 |
| Accounts Received In Advance |
6,021,950.81 |
| Employee Compensation Payable |
2,698,430.14 |
| Taxes Payable |
50,947,938.21 |
| Interest Payable |
228,016,935.21 |
| Dividend Payable |
1,265,460.00 |
| Other payables |
580,136,244.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
99,999,992.46 |
| Sub-Total of Current Liabilities |
858,839,790.44 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
206,071,577.72 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
70.20 |
| Sub-Total of Non-Current Liabilities |
206,071,647.92 |
| Total Liabilities |
1,064,911,438.36 |
| Paid-In Capital(Or Share Stock) |
336,441,600.00 |
| Capital Surplus |
219,290,712.51 |
| Surplus Reserve |
58,660,627.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-724,634,878.25 |
| Minority Stockholder's Interest |
9,533,945.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-110,241,938.45 |
| Owner's Equity（Stockholder's Equity） |
-100,707,992.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
964,203,445.59 |
